Watch APTX. Know when insiders buy.
One email the day a filing lands. Free.
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
| Report | Shares short | Change |
|---|---|---|
| 2026-09-30 | 1.5M | +319K |
| 2026-09-15 | 1.2M | +200K |
| 2026-08-31 | 1M | +85K |
| 2026-08-15 | 927K | +252K |
| 2026-07-31 | 676K | +452K |
| 2026-07-15 | 224K | −98K |
| Who | The call | Called | Return | Vs index |
|---|---|---|---|---|
| Brian Madden | Picked recently-IPO'd Apotex Health, projecting roughly 20% Canadian market share in generic semaglutide as Canada's largest pharma manufacturer.logged from a dated source | 2026-08-07 · $37.38 | −11.1% | −10.9 behind |